These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288 [TBL] [Abstract][Full Text] [Related]
8. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study. Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714 [TBL] [Abstract][Full Text] [Related]
9. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients. Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016 [TBL] [Abstract][Full Text] [Related]
10. Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis. Vallin M; Guillaud O; Boillot O; Hervieu V; Scoazec JY; Dumortier J Liver Transpl; 2014 Sep; 20(9):1064-71. PubMed ID: 24961607 [TBL] [Abstract][Full Text] [Related]
12. Dual alcohol and metabolic-related liver disease: Results from a population of liver transplant patients. Erard D; Villeret F; Chouik Y; Guillaud O; Scoazec JY; Caussy C; Disse E; Boillot O; Hervieu V; Dumortier J Liver Int; 2024 Feb; 44(2):422-432. PubMed ID: 38010979 [TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836 [TBL] [Abstract][Full Text] [Related]
15. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study. Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360 [TBL] [Abstract][Full Text] [Related]
16. The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Ester C; Cerban R; Iacob S; Pietrareanu C; Constantin G; Paslaru L; Ichim S; Lita M; Vadan R; Grancea C; Ruta S; Gheorghe C; Popescu I; Gheorghe L Chirurgia (Bucur); 2018; 113(4):534-541. PubMed ID: 30183584 [TBL] [Abstract][Full Text] [Related]
17. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874 [TBL] [Abstract][Full Text] [Related]
18. Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation. Nagpal SJ; Kabbany MN; Mohamad B; Lopez R; Zein NN; Alkhouri N Dig Dis Sci; 2016 Jul; 61(7):2102-7. PubMed ID: 26993824 [TBL] [Abstract][Full Text] [Related]